登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002731 证券简称：萃华珠宝 公告编号：2025-076 沈阳萃华金银珠宝股份有限公司 第六届董事会2025年第五次临时会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 沈阳萃华金银珠宝股份有限公司（以下简称"公司"）于2025年11月21日上午10：00在成都市高新西区金 泉街道蜀西路96号3楼会议室召开第六届董事会2025年第五次临时会议。会议通知已于2025年11月14日 通过邮件及书面等形式发出，本次会议由董事长陈思伟先生主持，应参与表决董事9人（包括独立董事3 人），实际参与表决董事9人。本次会议以现场结合视频方式召开。会议的召集、召开符合《公司法》 和《公司章程》的相关规定，会议合法有效。会议采用记名投票方式进行了表决，审议通过了如下决 议： 一、审议通过《关于转让控股孙公司磷氟锂业部分股权的议案》 为更好促进控股孙公司湖北磷氟锂业有限公司（以下简称"磷氟锂业"）发展，提升磷氟锂业经营实力， 充分发挥股东各方优势，公司于2025年11月21日召开第六届董事会2025年第五次 ...

| | | 11月25日重要公告精选 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 热点 | *ST东通 | 公司股票停牌暨可能被终止上市 | | | 富森美 | 副总经理、董事会秘书张风术被立案调查并实施留置措施 | | 签约项目 | 两面针 | 拟实施"两面针中草药功能性口腔护理产品生产基地扩建项目" | | 合同中标 | 三星医疗 | 预中标1.07亿元国家电网招标采购项目 | | 股权转让 | 苏州高新 | 拟6.04亿元向苏高新国控出售医疗器械产业公司47%股权 | | 回购 | 恒铭达 | 已累计回购2%股份 | | 增减持 | 万润股份 | 实际控制人拟增持3.65亿元-7.3亿元公司股份 | | 其他 | 申菱环境 | 拟发行可转债募资不超过10亿元用于液冷新质智造基地项目等 | | | 昂利康 | 拟定增募资11.6亿元用于创新药研发及产业化项目 写 節隆に | 【热点】 富森美(002818.SZ)：副总经理、董事会秘书张凤术被立案调查并实施留置措施 *ST东通（维权）(300379.SZ)：公司股票停牌暨可能被终止上市 【项目投资】 ST思科瑞（维 ...

智通财经APP讯，天奇股份(002009.SZ)公告，公司拟以1.3亿元的对价将其持有的优奇智能7%股权转让 给优奇智能控股股东优必选科技。交易完成后，优必选科技直接持有优奇智能41.4906%股权，公司及 全资子公司江苏天奇博瑞智能装备发展有限公司(简称"天奇博瑞")合计持有优奇智能22.4910%股权，其 中公司直接持有优奇智能16.1596%股权，天奇博瑞持有优奇智能6.3314%股权。 公告称，优奇智能为公司与优必选科技战略合作的重要平台。本次交易旨在支持优奇智能持续加速发 展，有利于优化优奇智能的股东结构及内部治理结构，为其后续开展独立资本化运作奠定基础，进一步 巩固其持续经营能力和市场竞争优势。 ...

Core Viewpoint - Suzhou Gaoxin plans to sell a 47% stake in Suzhou Medical Device Industry Development Group for 604 million yuan, aiming to reduce the impact of the medical device company's underperformance on its financial statements [1][2]. Group 1: Transaction Details - The transaction price of 604 million yuan is based on an asset valuation report, reflecting a 12.93% premium over the book value of the stake [2]. - The payment will be made in installments, with 51% due by January 7, 2026, and the remaining 49% by March 31, 2026 [2]. - Suzhou Gaoxin's cost basis for the stake was 535 million yuan, indicating a transaction premium [2]. Group 2: Company Performance - Suzhou Medical Device Industry Development Group reported a revenue of 152 million yuan for 2024 and a net loss of approximately 81.81 million yuan [1]. - For the first three quarters of 2025, the company generated 140 million yuan in revenue with a net loss of about 101 million yuan [1]. Group 3: Strategic Implications - The sale is expected to enhance Suzhou Gaoxin's overall profitability by reducing the negative impact of the medical device company's performance on its financials [3]. - The company will continue to manage existing funds and projects while focusing on quality enterprises in the medical device sector and promoting green low-carbon industrial park operations [3].

Core Viewpoint - Ningbo Energy Group Co., Ltd. plans to publicly transfer a 15% stake in Ningbo Lingfeng Comprehensive Energy Service Co., Ltd. at a base price of 16.0625 million yuan through its wholly-owned subsidiary, Ningbo Beilun Heating Co., Ltd. [2][4] Group 1: Transaction Overview - The transaction involves the transfer of a 15% stake in Lingfeng Energy due to reduced synergy with the company's main business [4]. - The board of directors unanimously approved the transaction during a meeting held on November 21, 2025, with all nine directors present [5]. - The transaction does not constitute a major asset restructuring and does not require shareholder approval [3][6]. Group 2: Transaction Details - The transfer will be conducted through a public listing, with the final transaction price and buyer still uncertain [6]. - The base price of 16.0625 million yuan is set above the assessed value of 15.308205 million yuan by 4.93% [7]. Group 3: Impact on the Company - The transaction is expected to adhere to principles of fairness and justice, and it will not have a significant adverse impact on the company's financials or operations [8].

登录新浪财经APP 搜索【信披】查看更多考评等级 ■ 上述增持主体存在一致行动人： 证券代码：603128证券简称：华贸物流公告编号：2025-027 港中旅华贸国际物流股份有限公司 增持股份进展公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 港中旅华贸国际物流股份有限公司（以下简称"公司"）于2025年10月10日发布《关于控股股东增持股 份及增持计划的公告》，公司控股股东中国物流集团有限公司的全资子公司中国物流集团资本管理有限 公司（以下简称"资本管理有限公司"）计划自2025年10月9日起6个月内，通过上海证券交易所交易系统 以集中竞价交易方式增持公司股份，增持金额不低于人民币0.645亿元，不超过人民币1.29亿元。 截止2025年11月21日，资本管理有限公司已通过集中竞价交易方式增持公司股份4,049,530股。 ● 增持计划无法实施风险：本次增持计划可能因资本市场情况变化等因素影响存在不确定性。 一、增持主体的基本情况 （二）本次增持计划是否导致公司控股股东及实际控制人发生变化 ...

Group 1 - The company held its 22nd meeting of the 6th Board of Directors on November 20, 2025, via telecommunication, with all 8 directors present, meeting the legal quorum requirements [2][3][6] - The Board approved the proposal to conclude the fundraising project for issuing convertible bonds and to permanently supplement the remaining funds of 223.2049 million yuan into working capital for daily operations and business development [3][4][39] - The proposal to convene the second extraordinary general meeting of shareholders in 2025 was also approved, scheduled for December 10, 2025 [9][10][11] Group 2 - The company plans to transfer 90% of its wholly-owned subsidiary, Suzhou Jinlaike Precision Machinery Co., Ltd., to Suzhou Chuangyuan Resource Recycling Co., Ltd., with an intended total equity value of 235 million yuan [44][46] - This transaction does not constitute a related party transaction or a major asset restructuring, and the signed letter of intent is preliminary, subject to further due diligence and negotiations [45][46][66] - The decision to sell the subsidiary aims to optimize the company's asset structure and resource allocation, enhancing operational efficiency and reducing management costs [65]

Core Viewpoint - The company has signed a share transfer agreement with its controlling shareholder, Shanghai Fengwang, to acquire 6% equity in Hebei Aihua Data Technology Co., Ltd. for 3 million yuan, aiming to enhance its influence and competitiveness in the IDC industry [1] Group 1 - The transaction constitutes a related party transaction and does not require approval from the shareholders' meeting [1] - Upon completion of the transaction, the company will hold 6% equity in Aihua Data [1] - The acquisition is part of the company's strategic development plan [1]

Core Viewpoint - The company, Yabao Pharmaceutical, plans to sell 62% of its subsidiary, Taiyuan Pharmaceutical, to Shanxi Tongxiang Times Technology for a transaction price of 87.1887 million yuan, aiming to enhance operational efficiency and support future business expansion [1] Group 1: Transaction Details - The transaction involves the sale of 62% equity of Taiyuan Pharmaceutical to Tongxiang Technology for 87.1887 million yuan [1] - The company anticipates that the transaction will increase its total profit by approximately 59 million yuan in 2025, based on preliminary calculations [1] Group 2: Strategic Rationale - The sale is part of a comprehensive consideration for the company's future development, aimed at improving asset operation efficiency and reducing management costs [1] - The transaction is expected to enhance the company's ongoing operational capabilities and provide financial support for business expansion [1] Group 3: Employee and Management Changes - Employee placement at Taiyuan Pharmaceutical has been completed prior to the transaction [1] - Post-transaction, the management of Taiyuan Pharmaceutical will be nominated by Tongxiang Technology [1]

Core Viewpoint - ST Jinggu (600265.SH) plans to transfer 51% equity stake in Huiyin Wood Industry to Chow Tai Fook Investment for approximately 133 million yuan, aiming to isolate debts, lawsuits, and operational risks [1] Group 1: Transaction Details - The transaction will be conducted in cash, with a total price of about 133 million yuan [1] - By divesting the 51% stake, the company aims to mitigate adverse impacts on its overall operations [1] Group 2: Financial Impact - The transaction is expected to lower the company's debt-to-asset ratio, thereby improving its financial condition and operational performance [1] - This move is anticipated to enhance the company's ability to sustain ongoing operations, positively influencing its business [1]